Twin Stock
HealthTechLooking to sell Twin stock or options?
Twin is the developer of a precision health platform aimed at diagnosing and repairing metabolic damage in diabetic patients. This innovative platform leverages artificial intelligence, IoT, and digital technologies to gain insights into metabolic dysfunction. By combining data, a unique digital twin AI technology, and expert analysis from a clinical care team, Twin creates a comprehensive view of each individual's metabolism. This approach enables the identification and repair of damaged metabolic pathways, which are the root cause of diabetes. Consequently, Twin empowers doctors to formulate precision treatments tailored for diabetic patients.
Maj Invest, Corner Ventures, Peak XV Partners, Temasek Holdings, Helena Special Investments, Benchmark Capital Holdings, Tru Arrow Partners, Sofina, DAG Ventures, LTS Growth.